Deevakar Rogith1, Rafeek A Yusuf1, Shelley R Hovick2, Susan K Peterson3, Allison M Burton-Chase4, Yisheng Li3, Funda Meric-Bernstam3, Elmer V Bernstam5. 1. The University of Texas School of Biomedical Informatics, Houston, Texas, USA. 2. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA The Ohio State University, Columbus, Ohio, USA. 3. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 4. The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Albany College of Pharmacy and Health Sciences, Albany, New York, USA. 5. The University of Texas School of Biomedical Informatics, Houston, Texas, USA Division of General Internal Medicine, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Abstract
OBJECTIVE: To evaluate attitudes regarding privacy of genomic data in a sample of patients with breast cancer. METHODS: Female patients with breast cancer (n=100) completed a questionnaire assessing attitudes regarding concerns about privacy of genomic data. RESULTS: Most patients (83%) indicated that genomic data should be protected. However, only 13% had significant concerns regarding privacy of such data. Patients expressed more concern about insurance discrimination than employment discrimination (43% vs 28%, p<0.001). They expressed less concern about research institutions protecting the security of their molecular data than government agencies or drug companies (20% vs 38% vs 44%; p<0.001). Most did not express concern regarding the association of their genomic data with their name and personal identity (49% concerned), billing and insurance information (44% concerned), or clinical data (27% concerned). Significantly fewer patients were concerned about the association with clinical data than other data types (p<0.001). In the absence of direct benefit, patients were more willing to consent to sharing of deidentified than identified data with researchers not involved in their care (76% vs 60%; p<0.001). Most (85%) patients were willing to consent to DNA banking. DISCUSSION: While patients are opposed to indiscriminate release of genomic data, privacy does not appear to be their primary concern. Furthermore, we did not find any specific predictors of privacy concerns. CONCLUSIONS: Patients generally expressed low levels of concern regarding privacy of genomic data, and many expressed willingness to consent to sharing their genomic data with researchers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: To evaluate attitudes regarding privacy of genomic data in a sample of patients with breast cancer. METHODS: Female patients with breast cancer (n=100) completed a questionnaire assessing attitudes regarding concerns about privacy of genomic data. RESULTS: Most patients (83%) indicated that genomic data should be protected. However, only 13% had significant concerns regarding privacy of such data. Patients expressed more concern about insurance discrimination than employment discrimination (43% vs 28%, p<0.001). They expressed less concern about research institutions protecting the security of their molecular data than government agencies or drug companies (20% vs 38% vs 44%; p<0.001). Most did not express concern regarding the association of their genomic data with their name and personal identity (49% concerned), billing and insurance information (44% concerned), or clinical data (27% concerned). Significantly fewer patients were concerned about the association with clinical data than other data types (p<0.001). In the absence of direct benefit, patients were more willing to consent to sharing of deidentified than identified data with researchers not involved in their care (76% vs 60%; p<0.001). Most (85%) patients were willing to consent to DNA banking. DISCUSSION: While patients are opposed to indiscriminate release of genomic data, privacy does not appear to be their primary concern. Furthermore, we did not find any specific predictors of privacy concerns. CONCLUSIONS:Patients generally expressed low levels of concern regarding privacy of genomic data, and many expressed willingness to consent to sharing their genomic data with researchers. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Mario Grassi; Andrea Nucera; Elisabetta Zanolin; Ernst Omenaas; Josep M Anto; Bénédicte Leynaert Journal: Value Health Date: 2007 Nov-Dec Impact factor: 5.725
Authors: Amy L McGuire; Rebecca Fisher; Paul Cusenza; Kathy Hudson; Mark A Rothstein; Deven McGraw; Stephen Matteson; John Glaser; Douglas E Henley Journal: Genet Med Date: 2008-07 Impact factor: 8.822
Authors: Mark I McCarthy; Gonçalo R Abecasis; Lon R Cardon; David B Goldstein; Julian Little; John P A Ioannidis; Joel N Hirschhorn Journal: Nat Rev Genet Date: 2008-05 Impact factor: 53.242
Authors: Stacy W Gray; Katherine Hicks-Courant; Christopher S Lathan; Levi Garraway; Elyse R Park; Jane C Weeks Journal: J Oncol Pract Date: 2012-08-07 Impact factor: 3.840
Authors: Susan Brown Trinidad; Stephanie M Fullerton; Julie M Bares; Gail P Jarvik; Eric B Larson; Wylie Burke Journal: Genet Med Date: 2010-08 Impact factor: 8.822
Authors: Deevakar Rogith; Rafeek A Yusuf; Shelley R Hovick; Bryan M Fellman; Susan K Peterson; Allison M Burton-Chase; Yisheng Li; Elmer V Bernstam; Funda Meric-Bernstam Journal: Int J Med Inform Date: 2016-01-18 Impact factor: 4.046
Authors: Goldy C George; Adrianna Buford; Kenneth Hess; Sarina A Piha-Paul; Ralph Zinner; Vivek Subbiah; Christina Hinojosa; Charles S Cleeland; Funda Meric-Bernstam; Elmer V Bernstam; David S Hong Journal: JCO Clin Cancer Inform Date: 2018-12
Authors: Laura A Siminoff; Maureen Wilson-Genderson; Maghboeba Mosavel; Laura Barker; Jennifer Trgina; Heather M Traino Journal: Genet Test Mol Biomarkers Date: 2017-01-25
Authors: Melissa Raspa; Ryan S Paquin; Derek S Brown; Sara Andrews; Anne Edwards; Rebecca Moultrie; Laura Wagner; MaryKate Frisch; Lauren Turner-Brown; Anne C Wheeler Journal: Value Health Date: 2020-10-26 Impact factor: 5.725
Authors: Lillian L Siu; Mark Lawler; David Haussler; Bartha Maria Knoppers; Jeremy Lewin; Daniel J Vis; Rachel G Liao; Fabrice Andre; Ian Banks; J Carl Barrett; Carlos Caldas; Anamaria Aranha Camargo; Rebecca C Fitzgerald; Mao Mao; John E Mattison; William Pao; William R Sellers; Patrick Sullivan; Bin Tean Teh; Robyn L Ward; Jean Claude ZenKlusen; Charles L Sawyers; Emile E Voest Journal: Nat Med Date: 2016-05-05 Impact factor: 53.440